Culturally Relevant Supportive Care for Advanced Cancer
Trial Summary
What is the purpose of this trial?
To determine the feasibility of implementing a culturally adapted mind-body intervention (Meditation-Based Support-Adapted; MBS-A) as a supportive care strategy in Black patients diagnosed with a stage III-IV solid malignancy. To target the specific needs of Black advanced cancer patients, we will first conduct formative research that includes quantitative surveys and in-depth interviews of patients and their primary caregivers. The purpose of this formative research is to determine the intervention format for the MBS-A program (family- vs group-based) that promises the greatest likelihood of success and to solicit input on the original MBS intervention regarding content that needs adaptation. Once the intervention format is determined and content adapted, we will conduct a pilot randomized controlled trial (RCT) to examine the feasibility of the MBS-A intervention vs. a dose-matched attention control (AC) group receiving a psychoeducation intervention.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment since the study involves a supportive care strategy and not a new drug.
What data supports the effectiveness of the treatment Meditation-Based Support-Adapted (MBS-A) for advanced cancer?
Research shows that mindfulness-based interventions, like the Meditation-Based Support-Adapted (MBS-A), can improve psychological well-being and reduce suffering in patients with advanced cancer. These treatments have been found to enhance quality of life and coping skills in cancer patients, suggesting they may be beneficial as supportive care.12345
Is the Meditation-Based Support-Adapted (MBS-A) treatment safe for humans?
How is the Meditation-Based Support-Adapted (MBS-A) treatment different from other treatments for advanced cancer?
The Meditation-Based Support-Adapted (MBS-A) treatment is unique because it focuses on mindfulness and cultural relevance, aiming to improve psychological well-being and reduce suffering in advanced cancer patients by helping them find meaning and manage stress. Unlike traditional treatments, it incorporates mindfulness practices and is adapted to be culturally relevant, particularly for minority groups, enhancing its effectiveness and acceptance.1351011
Research Team
Dalnim Cho, PhD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for Black/African American individuals aged 18 or older with stage III-IV solid tumors, on active treatment, and have a performance status allowing daily activity. They must be able to consent and have internet access. If the program is family-based, they need a caregiver living with them who can also participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Formative Research
Conduct quantitative surveys and in-depth interviews to determine the intervention format for the MBS-A program
Pilot Randomized Controlled Trial (RCT)
Conduct a pilot RCT to examine the feasibility of the MBS-A intervention vs. a dose-matched attention control group
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Meditation-Based Support-Adapted (MBS-A) (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator